About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Nxera Pharma Co., Ltd.(4565) Summary

4565
TSE Prime
Nxera Pharma Co., Ltd.
1,022
JPY
-12
(-1.16%)
Dec 23, 1:57 pm JST
6.52
USD
Dec 22, 11:57 pm EST
Result
PTS
outside of trading hours
1,022.1
Dec 23, 1:55 pm JST
Summary Chart Historical News Financial Result
PER
PBR
1.36
Yield
ー%
Margin Trading Ratio
456.65
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
1,032 JPY 6.59 USD
Previous Close Dec 20
1,034 JPY 6.59 USD
High Dec 23, 9:00 am
1,038 JPY 6.63 USD
Low Dec 23, 9:26 am
1,008 JPY 6.44 USD
Volume
687,300
Trading Value
0.70B JPY 4.49M USD
VWAP
1023.69 JPY 6.54 USD
Minimum Trading Value
102,200 JPY 652 USD
Market Cap
0.09T JPY 0.59B USD
Number of Trades
1,148
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
High
1-Year Average
1,833
1-Year High Aug 29, 2024
10,428
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 65,700 7,166,700 109.08
Dec 6, 2024 55,100 7,152,100 129.80
Nov 29, 2024 28,900 7,027,400 243.16
Nov 22, 2024 15,400 7,032,400 456.65
Nov 15, 2024 14,500 6,987,900 481.92
Company Profile
Nxera Pharma Co., Ltd. is a drug discovery venture specializing in the development of drugs targeting membrane protein GPCRs in areas such as neurology, immunology, and gastroenterology.
Sector
Pharmaceuticals